Paper41342003
Experience with isavuconazole in lung transplant recipients with Aspergillus isolation in respiratory tract specimens: A multicenter, observational study.
Silva JT and 15 others. JHLT Open, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Experience with isavuconazole in lung transplant recipients with Aspergillus isolation in respiratory tract specimens: A multicenter, observational study. Papers, record 41342003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41342003
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Experience with isavuconazole in lung transplant recipients with Aspergillus isolation in respiratory tract specimens: A multicenter, observational study.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33562370 | Strategies for the Prevention of Invasive Fungal Infections after Lung Transplant. | J Fungi (Basel) | 2021 | https://conductscience.org/library/papers/33562370 | PubMed |
| 2 | 38280760 | Opportunistic Infections Post-Lung Transplantation: Viral, Fungal, and Mycobacterial. | Infect Dis Clin North Am | 2024 | https://conductscience.org/library/papers/38280760 | PubMed |
| 3 | 31767725 | Population Pharmacokinetics of Intravenous Isavuconazole in Solid-Organ Transplant Recipients. | Antimicrob Agents Chemother | 2020 | https://conductscience.org/library/papers/31767725 | PubMed |
| 4 | 38436619 | Pharmacological management of invasive mold infections in solid organ transplant recipients. | Expert Opin Pharmacother | 2024 | https://conductscience.org/library/papers/38436619 | PubMed |
| 5 | 28722255 | Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4. | Transpl Infect Dis | 2017 | https://conductscience.org/library/papers/28722255 | PubMed |
| 6 | 30900296 | Invasive Aspergillosis in solid-organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. | Clin Transplant | 2019 | https://conductscience.org/library/papers/30900296 | PubMed |
| 7 | 35512939 | Infectious Complications in Lung Transplant Recipients. | Thorac Surg Clin | 2022 | https://conductscience.org/library/papers/35512939 | PubMed |
| 8 | 23919557 | What is the impact of hypogammaglobulinemia on the rate of infections and survival in solid organ transplantation? A meta-analysis. | Am J Transplant | 2013 | https://conductscience.org/library/papers/23919557 | PubMed |
| 9 | 35710714 | Infections in lung transplanted patients: A review. | Pulmonology | 2024 | https://conductscience.org/library/papers/35710714 | PubMed |
| 10 | 22932790 | Aspergillus tracheobronchitis: report of 8 cases and review of the literature. | Medicine (Baltimore) | 2012 | https://conductscience.org/library/papers/22932790 | PubMed |
| 11 | 29960829 | Executive summary of clinical practice guideline for the management of invasive diseases caused by Aspergillus: 2018 Update by the GEMICOMED-SEIMC/REIPI. | Enferm Infecc Microbiol Clin (Engl Ed) | 2019 | https://conductscience.org/library/papers/29960829 | PubMed |
| 12 | 32699023 | Developments in lung transplantation over the past decade. | Eur Respir Rev | 2020 | https://conductscience.org/library/papers/32699023 | PubMed |
| 13 | 26883703 | Pharmacokinetics and Concentration-Dependent Efficacy of Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis. | Antimicrob Agents Chemother | 2016 | https://conductscience.org/library/papers/26883703 | PubMed |
| 14 | 29668068 | Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study. | Transpl Infect Dis | 2018 | https://conductscience.org/library/papers/29668068 | PubMed |
| 15 | 27273343 | Pharmacokinetic Assessment of Drug-Drug Interactions of Isavuconazole With the Immunosuppressants Cyclosporine, Mycophenolic Acid, Prednisolone, Sirolimus, and Tacrolimus in Healthy Adults. | Clin Pharmacol Drug Dev | 2017 | https://conductscience.org/library/papers/27273343 | PubMed |
| 16 | 23567625 | Risk factors and outcomes in lung transplant recipients with nodular invasive pulmonary aspergillosis. | J Infect | 2013 | https://conductscience.org/library/papers/23567625 | PubMed |
| 17 | 25940222 | Isavuconazole: A New Option for the Management of Invasive Fungal Infections. | Ann Pharmacother | 2015 | https://conductscience.org/library/papers/25940222 | PubMed |
| 18 | 36367924 | Isavuconazole for the Treatment of Invasive Mold Disease in Solid Organ Transplant Recipients: A Multicenter Study on Efficacy and Safety in Real-life Clinical Practice. | Transplantation | 2023 | https://conductscience.org/library/papers/36367924 | PubMed |
| 19 | 38773846 | Isavuconazole Versus Voriconazole as the First-line Therapy for Solid Organ Transplant Recipients With Invasive Aspergillosis: Comparative Analysis of 2 Multicenter Cohort Studies. | Transplantation | 2024 | https://conductscience.org/library/papers/38773846 | PubMed |
| 20 | 32463873 | Isavuconazole Is as Effective as and Better Tolerated Than Voriconazole for Antifungal Prophylaxis in Lung Transplant Recipients. | Clin Infect Dis | 2021 | https://conductscience.org/library/papers/32463873 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41342003
GET https://conductscience.org/api/papers/v1/41342003/references?page=2